Cover Image

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical Samples

Background: Cefiderocol is a siderophore cephalosporin that exhibits antimicrobial activity against most multi-drug resistant Gram-negative bacteria, including Enterobacterales, <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>, and <i>Stenotrophomonas malto...

Full description

Saved in:

Bibliographic Details
Main Authors:	Davide Carcione (Author), Claudia Siracusa (Author), Adela Sulejmani (Author), Roberta Migliavacca (Author), Alessandra Mercato (Author), Aurora Piazza (Author), Luigi Principe (Author), Nicola Clementi (Author), Nicasio Mancini (Author), Valerio Leoni (Author), Jari Intra (Author)
Format:	Book
Published:	MDPI AG, 2021-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
by: Davide Carcione, et al.
Published: (2021)

Antimicrobial Resistance Patterns of <i>Enterobacter cloacae</i> and <i>Klebsiella aerogenes</i> Strains Isolated from Clinical Specimens: A Twenty-Year Surveillance Study
by: Jari Intra, et al.
Published: (2023)

Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia
by: Szymon Viscardi, et al.
Published: (2024)

Production and Antibacterial Activity of Atypical Siderophore from <i>Pseudomonas</i> sp. QCS59 Recovered from <i>Harpachene schimperi</i>
by: Mashael A. Almuhawish, et al.
Published: (2024)

High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates
by: Lana Daoud, et al.
Published: (2023)

Comments: Siderophore production by uropathogenic <i>Escherichia coli</i>
by: Gokarn Karuna
Published: (2010)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024)

In Vitro Activity of a Novel Siderophore-Cephalosporin, GT-1 and Serine-Type β-Lactamase Inhibitor, GT-055, against <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i> and <i>Acinetobacter</i> spp. Panel Strains
by: Le Phuong Nguyen, et al.
Published: (2020)

Siderophore production by uropathogenic <i> <i><i><i>Escherichia</i></i></i> coli</i>
by: Vagrali Manjula
Published: (2009)

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in <i>Acinetobacter baumannii</i>
by: Natalia Kolesnik-Goldmann, et al.
Published: (2023)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023)

Cefiderocol for Severe Carbapenem-Resistant <i>A. baumannii</i> Pneumonia: Towards the Comprehension of Its Place in Therapy
by: Emanuele Rando, et al.
Published: (2021)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
by: Clara Ballesté-Delpierre, et al.
Published: (2022)

Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
by: Claudia Alteri, et al.
Published: (2024)

Anticandidal Activity of a Siderophore from Marine Endophyte <i>Pseudomonas aeruginosa</i> Mgrv7
by: Essam Kotb, et al.
Published: (2024)

New Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians
by: Davide Carcione, et al.
Published: (2023)

Higher Prevalence of Extended-Spectrum Cephalosporin-Resistant <i>Enterobacterales</i> in Dogs Attended for Enteric Viruses in Brazil Before and After Treatment with Cephalosporins
by: Marília Salgado-Caxito, et al.
Published: (2021)

Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
by: Matteo Mori, et al.
Published: (2023)

Advances in Mycobacterium siderophore-based drug discovery
by: Jun-li He, et al.
Published: (2011)

Whole-Genome Sequencing Investigation of a Large Nosocomial Outbreak Caused by ST131 H30Rx KPC-Producing <i>Escherichia coli</i> in Italy
by: Aurora Piazza, et al.
Published: (2021)

<i>Acinetobacter baumannii</i> Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt
by: Samira M. Hamed, et al.
Published: (2023)

Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and <i>Clostridioides difficile</i> Infections
by: Callyn Mariah Wren, et al.
Published: (2022)

Synthesis of New Cephalosporins of Expected Improved Activity and Resistance Against ï¢-Lactamases
by: Shakir M. Alwan, et al.
Published: (2017)

In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
by: Michela Padovani, et al.
Published: (2023)

Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against <i>Acinetobacter baumannii</i>
by: Viola Camilla Scoffone, et al.
Published: (2022)

Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics
by: Pauline Loupias, et al.
Published: (2019)

The inhibitory effect of Lactobacillus on siderophore production in Pseudomonas aeruginosa (in vitro).
by: Ali Murtatha Hasan
Published: (2018)

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022)

Characterization of Third Generation Cephalosporin- and Carbapenem-Resistant <i>Aeromonas</i> Isolates from Municipal and Hospital Wastewater
by: Sara Drk, et al.
Published: (2023)

Broad-Spectrum Cephalosporin-Resistant and/or Fluoroquinolone-Resistant <i>Enterobacterales</i> Associated with Canine and Feline Urogenital Infections
by: Igor Loncaric, et al.
Published: (2020)

Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
by: Márió Gajdács
Published: (2020)

The Resistance Mechanisms and Clinical Impact of Resistance to the Third Generation Cephalosporins in Species of <i>Ent</i><i>erobacter cloacae</i> Complex in Taiwan
by: Chung-Yu Chang, et al.
Published: (2022)

Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to <i>Enterobacter</i>, <i>Serratia</i>, and <i>Citrobacter</i> Species
by: Caroline Derrick, et al.
Published: (2020)

Molecular Characterization of Cephalosporin and Fluoroquinolone Resistant <i>Salmonella</i> Choleraesuis Isolated from Patients with Systemic Salmonellosis in Thailand
by: Pichapak Sriyapai, et al.
Published: (2021)

The Emergence of <i>Klebsiella pneumoniae</i> with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria
by: Kabiru O. Akinyemi, et al.
Published: (2021)

Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Complex in Germany
by: Kyriaki Xanthopoulou, et al.
Published: (2022)

In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from Italy
by: Bernardetta Segatore, et al.
Published: (2022)

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies
by: Julien Leenhardt, et al.
Published: (2023)

Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases
by: Gilda Tonziello, et al.
Published: (2019)